Xponance’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $899K | Buy |
22,754
+2,435
| +12% | +$96.2K | 0.01% | 728 |
|
|
2025
Q1 | $613K | Buy |
20,319
+980
| +5% | +$29.6K | 0.01% | 871 |
|
|
2024
Q4 | $676K | Buy |
19,339
+318
| +2% | +$11.1K | 0.01% | 855 |
|
|
2024
Q3 | $762K | Buy |
19,021
+906
| +5% | +$36.3K | 0.01% | 797 |
|
|
2024
Q2 | $863K | Buy |
18,115
+1,906
| +12% | +$90.8K | 0.01% | 722 |
|
|
2024
Q1 | $703K | Sell |
16,209
-484
| -3% | -$21K | 0.01% | 835 |
|
|
2023
Q4 | $844K | Sell |
16,693
-1,143
| -6% | -$57.8K | 0.01% | 733 |
|
|
2023
Q3 | $809K | Sell |
17,836
-430
| -2% | -$19.5K | 0.01% | 713 |
|
|
2023
Q2 | $749K | Buy |
18,266
+339
| +2% | +$13.9K | 0.01% | 754 |
|
|
2023
Q1 | $641K | Buy |
17,927
+217
| +1% | +$7.76K | 0.01% | 827 |
|
|
2022
Q4 | $669K | Buy |
17,710
+2,170
| +14% | +$82K | 0.01% | 789 |
|
|
2022
Q3 | $687K | Buy |
15,540
+122
| +0.8% | +$5.39K | 0.01% | 706 |
|
|
2022
Q2 | $571K | Buy |
15,418
+520
| +3% | +$19.3K | 0.01% | 808 |
|
|
2022
Q1 | $552K | Buy |
14,898
+8
| +0.1% | +$296 | 0.01% | 860 |
|
|
2021
Q4 | $453K | Buy |
14,890
+318
| +2% | +$9.68K | 0.01% | 938 |
|
|
2021
Q3 | $489K | Sell |
14,572
-654
| -4% | -$21.9K | 0.01% | 899 |
|
|
2021
Q2 | $607K | Buy |
15,226
+8,423
| +124% | +$336K | 0.01% | 821 |
|
|
2021
Q1 | $306K | Buy |
6,803
+23
| +0.3% | +$1.04K | 0.01% | 955 |
|
|
2020
Q4 | $383K | Buy |
6,780
+209
| +3% | +$11.8K | 0.01% | 866 |
|
|
2020
Q3 | $312K | Sell |
6,571
-215
| -3% | -$10.2K | 0.01% | 842 |
|
|
2020
Q2 | $400K | Buy |
+6,786
| New | +$400K | 0.01% | 707 |
|